Search
for
Sort by
Research 151–180 of 1000+
- Risk of Depression after 5 Alpha Reductase Inhibitor Medication: Meta-Analysis
- Correlation between individual inflammation genetic profile and platelet rich plasma efficacy in hair follicle regeneration: a pilot study reveals prognostic value of IL-1a polymorphism.
- Alopecia universalis following interferon alfa-2b and ribavirin treatment for hepatitis C.
- A Chinese–Japanese boy with black dot ringworm due to <i>Trichophyton violaceum</i>
- Risk of Acute Pancreatitis in Users of Finasteride
- Alopecia universalis after discontinuation of pegylated interferon and ribavirin combination therapy for hepatitis C: a case report
- Real-world assessment of ritlecitinib in patients with severe alopecia areata: a 24-week multicentre retrospective study
- Safety and Efficacy of Ritlecitinib for the Treatment of Patients with Alopecia Areata: A Systematic Review and Meta-Analysis of Controlled Trials
- Impact of Previous Alopecia Areata Treatment on Efficacy Responses up to Week 48 Following Ritlecitinib Treatment: A Post Hoc Analysis
- 67 Patterns of clinical response in patients with alopecia areata (AA) treated with ritlecitinib in the ALLEGRO phase 2b/3 and ongoing, phase 3, ALLEGRO-LT studies
- Canine Ringworm Caused by Trichophyton mentagrophytes - Detection by SYBR-Green real-time PCR
- A Systematic Review: Application of Rice Products for Hair Growth
- Bipolar Patients and Bullous Pemphigoid after Risperidone Long-Acting Injectable: A Case Report and a Review of the Literature
- Acquired Localized Hypertrichosis Induced by Rivastigmine
- Ringworm by Microsporum canis in Long-tailed chinchilla (Chinchilla lanigera)
- Endocrine abnormalities in ring chromosome 11: a case report and review of the literature
- Clinical experiments with Riboflavin, inositol and calcium Pantothenate
- Dystrophic-Anagen Effluvium Occurring During Pegylated Interferon-α-2a/Ribavirin Therapy
- SALT score distribution with ritlecitinib treatment up to 24 months in alopecia areata
- Alopecia Universalis in a Multiple Sclerosis Patient After Switching From Rituximab to Ocrelizumab: A Case Report
- Unraveling Ritlecitinib: an in-depth analysis of JAK3 inhibitor for the treatment of alopecia areata
- Risk Factors for the Development of and Outcomes After Diagnosis of Autoimmune Alopecia Areata in Patients with Inflammatory Bowel Diseases
- Patient-Reported Satisfaction with Hair Regrowth in a Study of Ritlecitinib in Alopecia Areata: Results from ALLEGRO-2b/3
- An Analysis of Risk Factors of Recipient Site Temporary Effluvium After Follicular Unit Excision: A Single-Center Retrospective Study
- Cardiovascular risk markers in premature canities
- A split face study to compare the efficacy of platelet rich plasma versus normal saline injections in acne scars and to assess the utility of ultrabiomicroscopic sonography in evaluation of treatment response
- Risk Analysis of Lurasidone in Patients with Schizophrenia and Bipolar Depression
- Can Pension Funds Partially Manage Longevity Risk by Investing in a Longevity Megafund?
- Microemulsion Formulation of Combination of Virgin Coconut Oil and Rice Bran Oil for Hair Growth
- RISK FACTORS, PREVALENCE AND DIAGNOSIS OF HUTCHISON GILFORD SYNDROME WITH SPECIAL REFERENCE TO CASE REPORTS